Connecticut HB 6152: AN ACT REQUIRING THE INCLUSION OF METHADONE IN THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM.

Status: CHG. REF., SEN. TO COMM. ON General Law (as of 2019-02-06)

State: Connecticut · Session: 2019 · Bill: HB 6152

Subjects: Drugs, Methadone, Electronic medical records

Sponsors: Rutigliano, David

Bill Text

LCO No. 2063 1 of 1

General Assembly Proposed Bill No. 6152
January Session, 2019 LCO No. 2063

Referred to Committee on PUBLIC HEALTH

Introduced by:
REP. RUTIGLIANO, 123rd Dist.

AN ACT REQUIRING THE INCLUSION OF METHADONE IN THE
ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:

That subsection (j) of section 21a-254 of the general statutes be 1
amended to require the Commissioner of Consumer Protection to 2
include methadone in the electronic prescription drug monitoring 3
program. 4
Statement of Purpose:
To require the reporting of methadone prescriptions through the
electronic prescription drug monitoring program.

View Connecticut HB 6152 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.